12-6826226-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_019858.2(GPR162):c.1088G>A(p.Arg363Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000524 in 1,614,022 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00028 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00055 ( 1 hom. )
Consequence
GPR162
NM_019858.2 missense
NM_019858.2 missense
Scores
1
6
12
Clinical Significance
Conservation
PhyloP100: 4.92
Genes affected
GPR162 (HGNC:16693): (G protein-coupled receptor 162) This gene was identified upon genomic analysis of a gene-dense region at human chromosome 12p13. It appears to be mainly expressed in the brain; however, its function is not known. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR162 | NM_019858.2 | c.1088G>A | p.Arg363Gln | missense_variant | 4/5 | ENST00000311268.8 | NP_062832.1 | |
GPR162 | NM_014449.2 | c.236G>A | p.Arg79Gln | missense_variant | 4/5 | NP_055264.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR162 | ENST00000311268.8 | c.1088G>A | p.Arg363Gln | missense_variant | 4/5 | 1 | NM_019858.2 | ENSP00000311528.3 | ||
GPR162 | ENST00000428545.6 | c.236G>A | p.Arg79Gln | missense_variant | 4/5 | 1 | ENSP00000399670.2 | |||
GPR162 | ENST00000382315.7 | c.176G>A | p.Arg59Gln | missense_variant | 3/4 | 1 | ENSP00000371752.3 | |||
GPR162 | ENST00000545321.1 | c.440G>A | p.Arg147Gln | missense_variant | 3/4 | 2 | ENSP00000475912.1 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152178Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
43
AN:
152178
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000261 AC: 65AN: 248988Hom.: 0 AF XY: 0.000237 AC XY: 32AN XY: 134774
GnomAD3 exomes
AF:
AC:
65
AN:
248988
Hom.:
AF XY:
AC XY:
32
AN XY:
134774
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000549 AC: 802AN: 1461726Hom.: 1 Cov.: 31 AF XY: 0.000534 AC XY: 388AN XY: 727174
GnomAD4 exome
AF:
AC:
802
AN:
1461726
Hom.:
Cov.:
31
AF XY:
AC XY:
388
AN XY:
727174
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000282 AC: 43AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.000282 AC XY: 21AN XY: 74464
GnomAD4 genome
AF:
AC:
43
AN:
152296
Hom.:
Cov.:
32
AF XY:
AC XY:
21
AN XY:
74464
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
5
ALSPAC
AF:
AC:
5
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
37
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2024 | The c.1088G>A (p.R363Q) alteration is located in exon 4 (coding exon 3) of the GPR162 gene. This alteration results from a G to A substitution at nucleotide position 1088, causing the arginine (R) at amino acid position 363 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
D;D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at